When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IDNA - ARKG: Massive Potential But Not Worth The Risk Yet For These 3 Reasons
iShares Genomics Immunology and Healthcare
2024-03-25 05:22:18 ET
Summary
ARK Genomic Revolution ETF warrants a hold rating due to multiple roadblocks preventing solid returns, including underdeveloped technology, legal hurdles, and unresolved ethical dilemmas.
ARKG has a relatively high expense ratio with no dividend yield, and its performance has significantly underperformed the S&P 500 Index.
The fund's holdings are concentrated in the healthcare sector, with little overlap with other peer genomics-related funds.